2016 Hematological Malignancies

First page Previous page 77 Next page Last page

HD15-PET trial Activity of residual masses ≥ 2.5cm by PET (n=728)*

PET-positive: PET-negative:

188 (26%) 540 (74%)

*Patients qualified for the PET question PET evaluated by PET panel

Made with